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An efﬁcient generic static headspace gas chromatography (HSGC) method was developed, optimized and
validated for the routine determination of several residual solvents (RS) in drug substance, using a
strategy with two sets of calibration. Dimethylsulfoxide (DMSO) was selected as the sample diluent and
internal standards were used to minimize signal variations due to the preparative step. A gas chroma-
tograph from Agilent Model 6890 equipped with ﬂame ionization detector (FID) and a DB-624
(30 m0.53 mm i.d., 3.00 mm ﬁlm thickness) column was used. The inlet split ratio was 5:1. The inﬂu-
encing factors in the chromatographic separation of the analytes were determined through a fractional
factorial experimental design. Signiﬁcant variables: the initial temperature (IT), the ﬁnal temperature
(FT) of the oven and the carrier gas ﬂow rate (F) were optimized using a central composite design.
Response transformation and desirability function were applied to ﬁnd out the optimal combination of
the chromatographic variables to achieve an adequate resolution of the analytes and short analysis time.
These conditions were 30 °C for IT, 158 °C for FT and 1.90 mL/min for F. The method was proven to be
accurate, linear in a wide range and very sensitive for the analyzed solvents through a comprehensive
validation according to the ICH guidelines.
& 2015 Xi'an Jiaotong University. Production and hosting by Elsevier B.V. All rights reserved. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Residual solvents (RS) are volatile organic chemicals (VOCs)
that are used or produced during the manufacturing process of
active pharmaceutical ingredients (APIs) or excipients and cannot
be completely removed. RS analysis of pharmaceutical products is
necessary not only because they represent a potential risk for
human health, due to their toxicity and their undesirable side ef-
fects, but also because they may affect the physicochemical
properties of pharmaceutical products. Therefore, it is a manda-
tory requirement for health authorities in the world to accurately
determine the levels of RS that are present in APIs or excipients
[1–3].
The International Conference on Harmonization (ICH) in their
guideline Q3C (R5) [4] classiﬁes the regularly used solvents into
three different classes based on their toxicity: Class 1 (solvents
that should be avoided due to their known carcinogenic effect on
human), Class 2 (solvents that should be limited in order to protecton and hosting by Elsevier B.V. All
University.
.
De Zan).patients from potential adverse effects), and Class 3 (solvents re-
garded as less toxic and of a lower risk for human health). Ac-
cording to ICH guidelines, the levels of Class 1 and 2 solvents
should be restricted to the concentration limits established by the
guideline. As regard to Class 3 solvents, amounts of up to 0.5% (w/
w) are considered acceptable. Moreover, the European Pharma-
copoeia (Ph. Eur.) and the United States Pharmacopoeia (USP) es-
tablish the maximum allowable limits of the RS in the APIs and
excipients, in accordance with the ICH guidelines.
The most appropriate analytical technique to determine RS and
organic volatile impurities is the capillary gas chromatography
(GC). The reasons why GC is highly recommended to this purpose
are its excellent separation ability, low detection limits and the
possibility of analyzing liquid or solid samples of variable and
complex nature. Most of the detectors used in GC are developed
speciﬁcally for this technique. There are probably more than 60
detectors that have been used in GC, and most of them are based
on the formation of ions by one means or another. Among them,
the ﬂame ionization detector (FID) becomes the most popular [5].
Mass spectrometers can also be used as detectors, properly cou-
pled to the chromatograph. The combination of GC with mass
spectroscopy has become a very popular and powerful tool [6].rights reserved. This is an open access article under the CC BY-NC-ND license
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graphy (SHGC) have gained ground against direct injection, mainly
because of the many disadvantages associated with the direct in-
jection of sample solution into the GC system [7]. In the SHGC
procedure, the liquid or solid sample is placed in a sealed vial and
thermostated until a thermodynamic equilibrium between the
sample and the gas phase is reached. A known aliquot of the gas
phase is then injected into the gas chromatograph and analyzed.
Therefore, any potential interference, from non-volatile sub-
stances, is removed or minimized.
It is worth noting that sample diluent has an important inﬂu-
ence on SHGC, affecting sensitivity, equilibration temperature and
time. In addition, the diluent should be able to dissolve a large
variety of samples, present a high boiling point and an acceptable
stability [8]. There are several commonly used sample diluents for
HSGC analyses, such as water, dimethylsulfoxide (DMSO), N,N-di-
methylformamide (DMF), N,N-dimethylacetamide (DMA), benzyl
alcohol (BA), 1,3-dimethyl-2-imidazolidinone (DMI) and mixtures
of water/DMF or water/DMSO [9]. Water is a good diluent for
water soluble samples, because it is clean, stable and inexpensive.
However, many organic synthetic drug substances and drug pro-
ducts have low water solubility. When mixtures of water/DMF or
water/DMSO are used as sample diluent, the solubility of many
drug substances or drug products increases and the partition
coefﬁcient of the analytes decreases, resulting in a better transfer
of analytes from the liquid to the gas phase. However, if the
sample solution is equilibrated at or above the boiling point of the
diluent, the inner pressure of the vial is dangerously increased [8].
This means that if water or water mixtures are chosen, the head
space (HS) equilibration temperature must be below 100 °C,
leading to poor volatilization of a large number of solvents with
higher boiling points. In contrast, the use of pure solvents such as
DMSO, DMF, DMA or DMI generally provides an adequate solubi-
lization of most of drug substances, and gives the possibility to
incubate at temperatures above 100 °C.
The sample pre-treatment involved in the SHGC procedure is a
critical step that may lead to experimental errors that can in-
validate the results of the analysis. A strategy used to overcome
errors in the preparative step is the addition of an internal stan-
dard (IS) [5]. The IS may be used for two different purposes. On the
one hand, it can be a substance or substances added to the sample
solution prior to injection in order to minimize the variability due
to the volume injected into the column. On the other hand, this
substance or substances is added to the sample at the earliest
possible point in an analytical scheme to compensate any loss
during the extraction step [10]. The IS must meet several criteria:
it should elute near the peaks of interest, but it must also be well
resolved from them; it should be chemically similar to the analytes
of interest, but it must not react with any sample component; and
it must be available in high purity.
The IS is added to the sample in a concentration similar to that
of the analyte(s) of interest. When several components are ana-
lyzed, it may not be possible to fulﬁll this condition and a con-
centration of IS between higher and lower concentrations of the
analytes to be analyzed must be chosen. Moreover, if many ana-
lytes are to be determined simultaneously, several internal stan-
dards may be used to meet the preceding criteria [10]. The de-
velopment of such a complex analytical method requires an ap-
propriate optimization procedure.
When attempting to ﬁnd the factors (k) that have a signiﬁcant
inﬂuence on the system under study and then optimize such a
system, experimental design is a powerful tool that is increasingly
being used [11]. The advantages of experimental design are well
known by chemometricians in particular and, increasingly, by the
scientiﬁc community in general. Especially, its use in separation
science has increased in the last few years [12–17].Response surface methodology (RSM) is a collection of statis-
tical and mathematical techniques used to develop, improve and
optimize processes. One of the strengths of RSM is that it may
work well in cases where there is incomplete knowledge about the
state and behavior of the system under study as long as the system
is stable and there is reasonable correspondence between set
points and actual conditions [18]. There are several experimental
designs suitable for this purpose, which vary in the number of
experiments required and in the complexity of the mathematical
models that can be built to describe the relationship between the
factors and the responses under study [11]. Using a factorial design
in the screening phase followed by a central composite design
(CCD) in the optimization stage is an effective tool in the optimi-
zation of a process with several parameters [19].
In addition, when different objective functions (responses)
have to be optimized simultaneously, the so-called “Derringer's
desirability function” is a useful strategy. This function is based on
the idea that the quality of a product or process that has many
features is completely unacceptable if one of them is outside a
“desirable” limit. Its aim is to ﬁnd operating conditions that ensure
compliance with the criteria of all the involved responses and, at
the same time, to provide the best value of compromise in the
desirable joint response. This is achieved by converting the mul-
tiple responses into a single one, combining the individual re-
sponses into a composite function followed by its optimization
[20,21]. In the ﬁrst step of this methodology, a partial desirability
function (di) must be created for each individual response using
the ﬁtted models and establishing the optimization criteria. The
most desirable ranges for each design factor or response are se-
lected by the user, based on the prior knowledge of the system
including the researcher's priorities during the optimization pro-
cedure. This involves deciding if these factors or responses have to
be maximized, minimized, maintained in the range or reach a
target value. In addition, a weight (wi) or emphasis is given to each
goal. After that, the global desirability function (D) is obtained
using the following equation:
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where n is the number of variables included in the optimization
procedure, and rn is the importance of each factor or response
relative to the others.
The n variables, transformed in desirability functions, are
combined in a unique function (D) to ﬁnd out the best joint re-
sponses. The optimization procedure implies maximizing D.
Derringer's desirability function allows the analyst to ﬁnd the
experimental conditions (factor levels) to reach simultaneously
the optimal value for all the evaluated variables. When D reaches a
value other than zero, all the variables which are being simulta-
neously optimized can be considered having a desirable value.
Meanwhile, if one of the responses is completely undesirable, D
will be zero.
In this work, an SHGC method was developed, optimized and
validated for the simultaneous determination of methanol, etha-
nol, ethyl ether, acetone, 2-propanol, acetonitrile, methylene
chloride, hexane, isopropyl ether, ethyl acetate, 2-butanone,
chloroform, tetrahydrofuran, cyclohexane, benzene, heptane, iso-
octane, triethylamine, 1-butanol, trichloroethylene, 1,4-dioxane,
propyl acetate, pyridine, toluene, ethylene glycol, carbon tetra-
chloride, DMF, m-xylene, p-xylene, o-xylene and DMSO as RS in
raw material.
Table 1
Concentration ranges for analytes in the ﬁrst calibration set.
Analyte Range (mg/mL)
Propyl acetate 2.99–89.7
Acetone 3.00–90.1
1-Butanol 47.8–77.6
Cyclohexane 2.99–89.7
Ethanol 2.99–89.9
Ethyl ether 2.99–89.8
Methanol 15.1–90.3
Ethyl acetate 15.0–89.8
Heptane 3.00–90.3
Hexane 1.44–8.64
2-Propanol 15.0–90.1
Isopropyl ether 15.0–90.1
Tetrahydrofuran 0.46–13.9
Toluene 2.95–17.7
Xylene 3.01–90.3
Table 2
Concentration ranges of analytes in the second calibration set.
Analyte Range (mg/mL)
Acetonitrile 5.03–8.17
Methylene chloride 9.31–15.1
2-Butanone 47.8–77.6
Chloroform 0.95–1.54
Benzene 0.034–0.055
Triethylamine 0.79–1.28
Trichloroethylene 1.31–2.13
1,4-Dioxane 6.59–10.7
Pyridine 3.21–5.21
Ethylene glycol 9.29–15.1
Carbon tetrachloride 0.061–0.099
N,N-dimethylformamide 14.5–23.6
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2.1. Apparatus and software
All experiments were performed using a gas chromatograph
Model 6890 (Agilent, Wilmington, DE, USA) equipped with FID.
The Chemstation version B 0103 was used for data acquisition and
processing. The GC column was a DB-624 (30 m0.53 mm i.d.,
3.00 mm ﬁlm thickness) from Agilent. The inlet split ratio was 5:1.
Experimental design, surface response modeling and desir-
ability function calculations were performed using the Design-
Expert 8.0.0 (Stat-Ease Inc., Minneapolis).
2.2. Chemicals and reagents
DMSO was purchased from TEDIA (Fairﬁeld, Ohio, USA). Me-
thanol, ethanol, ethyl ether, acetone, methylene chloride, hexane,
isopropyl ether, ethyl acetate, 2-butanone, isooctane, chloroform,
tetrahydrofuran, cyclohexane, triethylamine, 1-butanol, tri-
chloroethylene, 1,4-dioxane, propyl acetate, pyridine, toluene,
ethylene glycol, DMF, and total xylenes were supplied by Anedra
(San Fernando, Argentina), and 2-propanol, acetonitrile, benzene,
heptane and carbon tetrachloride by Cicarelli (San Lorenzo, Ar-
gentina). Metronidazole benzoate raw material and betametha-
sone-17 valerate raw material used as validation samples were
supplied by Lafedar S.A. (Parana, Argentina).
2.3. Calibration curves and internal standard selection
To perform the calibration curves, the concentrations of each
analyte were deﬁned. In order to obtain the same parity, the sol-
vents were separated, according to their concentration limits, into
two groups: solvents with high limits and solvents with low limits.
Another aspect that was considered was the overlapped peaks
of some analytes for which no separation was achieved in the
optimization procedure (ethyl acetate-2-butanone, chloroform-
tetrahydrofuran, heptanes-isooctane-triethylamine, dioxane-propyl
acetate and toluene-ethylene glycol). A particular case resided in
the determination of three coeluting analytes: isooctane–hep-
tane–triethylamine. In this case, a bibliographic study of the oc-
currence of these solvents in raw materials allowed us to decide to
work with heptane–triethylamine.
In addition, two internal standards were selected in each cali-
bration group, one in low concentration and the other in high
concentration. To deﬁne the solvent used as IS, we considered the
resolutions between the peaks and co-eluting analytes and the
characteristics of the solvents. According to these issues, we
decided to use benzene, trichloroethylene, acetone and hexane. Its
reproducibility during the runs was an important parameter to
consider in the choice of the IS.
2.4. Internal standard solutions
Two internal standard solutions were prepared by diluting
appropriate volumes of pure solvents in DMSO. For internal
standard solution 1 (IS1), 12 mL of benzene and 410 mL of tri-
chloroethylene were transferred into a 10 mL volumetric ﬂask. For
internal standard solution 2 (IS2), 115 mL of hexane and 250 mL of
acetone were transferred into a 10 mL volumetric ﬂask.
2.5. Standard solutions
Two standard stock solutions (SSSs) were prepared by diluting
appropriate volumes of pure solvents of each analyte in DMSO.
Calibration standards were prepared at the moment of the analysis
by diluting suitable volumes of the SSSs in DMSO. By properdilutions, the ﬁrst SSS calibration solutions were obtained yielding
concentrations of analytes in the ranges described in
Table 1. Then, 25 mL of IS1 was added into each calibration solution
reaching concentrations of 2.0 mg/mL for benzene and 60 mg/mL
for trichloroethylene. With the similar method, the second SSS
calibration solutions were obtained yielding concentrations of
analytes in the ranges described in Table 2. Then, 25 mL of IS2 was
added into each solution obtaining concentrations of 0.4 mg/mL for
hexane and 20 mg/mL for acetone. After incubation of the solutions
(5.0 mL in a 20 mL headspace vial) at 105 °C for 45 min, 2.5 mL of
the vapor phase was injected into the GC system.
2.6. Sample preparation
500 mg of metronidazole benzoate or betamethasone-17 vale-
rate raw material was transferred into a 25 mL volumetric ﬂask
and an amount of DMSO (15 mL) was added to dissolve the sam-
ple. In the case of betamethasone-17 valerate, the analytes to be
identiﬁed and quantiﬁed were chloroform, trichlorethylene, di-
oxane, DMF and ethyl acetate, and the IS2 (25 mL) was used. In the
case of metronidazole benzoate, the analytes to be identiﬁed and
quantiﬁed were methanol, acetone, methylene chloride, ethylene
glycol and toluene, and the IS1was used. After incubation of the
sample (5.0 mL in a 20 mL headspace vial) at 105 °C for 45 min,
2.5 mL of the vapor phase was injected into the GC system.
2.7. Fortiﬁed samples for recovery and precision studies
Portions of 500 mg of metronidazole benzoate raw material or
betamethasone-17 valerate raw material were transferred into
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solvents yielding concentrations of analytes in the ranges de-
scribed in Table 3 and Table 4. After that, DMSO (15 mL) was added
to dissolve the sample and 25 mL of IS (IS1 or IS2) was added. After
incubation of the sample (5.0 mL in a 20 mL headspace vial) at
105 °C for 45 min, 2.5 mL of the vapor phase was injected into the
GC system.
2.8. Experimental design and optimization
The goal of using experimental design was to ﬁnd the optimal
analytical conditions for the chromatographic separation of 31
solvents with satisfactory performance and in a reasonable ana-
lysis time.
In the ﬁrst instance, runs were performed using the USP 34
method for residual solvents. The column was a DB-624
(30 m0.53 mm i.d., 3.00 mm ﬁlm thickness) from Agilent. The
inlet split ratio was 5:1, and the carrier gas was nitrogen at a ve-
locity of 5.0 mL/min. The column temperature was maintained at
40 °C for 20 min, then raised at a rate of 10 °C per min to 240 °C
and maintained at 240 °C for 20 min. Fig. 1 shows a typical chro-
matogram obtained from these conditions.
These previous experiments showed low or none resolutionTable 3
Concentration levels (μg/mL) for analytes of the ﬁrst calibration set used for pre-
cision and recovery studies.
Analyte Recovery study Precision study Repeatability
study
1a 2a 3a 4a 1b 2b
Propyl acetate 5.98 44.7 59.8 83.7 2.99 89.7 59.8
Acetone 6.00 45.0 60.0 84.1 3.00 90.1 60.0
1-Butanol 6.03 45.3 60.3 84.5 3.02 90.5 60.3
Cyclohexane 5.98 44.9 59.8 83.8 2.99 89.8 59.8
Ethanol 6.00 45.0 60.0 83.9 3.00 98.9 59.9
Ethyl ether 5.99 44.9 59.9 83.9 3.00 89.8 59.9
Methanol 6.02 45.1 60.2 84.3 3.01 90.3 60.2
Ethyl acetate 5.99 44.9 59.9 83.9 3.00 89.8 59.9
Heptane 6.02 45.1 60.2 84.3 3.01 90.3 60.2
Hexane 0.58 4.32 5.76 8.06 0.29 8.64 5.76
2-Propanol 6.01 45.1 60.1 84.1 3.00 90.1 60.1
Isopropyl ether 6.00 45.0 60.0 84.0 3.00 90.1 60.0
Tetrahydrofuran 0.93 6.95 9.26 13.0 0.46 13.9 9.26
Toluene 1.18 8.84 11.8 16.5 0.59 17.7 11.8
Xylene 6.02 45.2 60.2 84.3 3.01 90.3 60.2
a Fortiﬁcation level in recovery study.
b Fortiﬁcation level in precision study.
Table 4
Concentration levels (μg/mL) for analytes of the second calibration set used for precisio
Analyte Recovery study
1a 2a 3a
Acetonitrile 5.97 6.29 6.60
Methylene chloride 11.1 11.6 12.2
2-Butanone 56.7 59.7 62.7
Chloroform 1.12 1.18 1.24
Benzene 0.040 0.042 0.044
Triethylamine 0.94 0.99 1.04
Trichloroethylene 1.55 1.64 1.72
1,4-Dioxane 7.83 8.24 8.65
Pyridine 3.81 4.01 4.21
Ethylene glycol 11.0 11.6 12.2
Carbon tetrachloride 0.070 0.076 0.080
N,N-dimethylformamide 17.2 18.1 19.0
a Fortiﬁcation level in recovery study.
b Fortiﬁcation level in precision study.between several of the analyzed solvents and in some cases large
peaks widths. Thus, we built an experimental design to determine
the factors that were inﬂuencing the separation and peaks per-
formance. A factorial design with six factors was used: (a) initial
temperature of the GC oven in the range of 40–60 °C; (b) ﬁnal
temperature of the GC oven in the range of 100–150 °C; (c) time
period of initial temperature in the range of 1–3 min; (d) timen and recovery studies.
Precision study Repeatability study
4a 1b 2b
7.86 5.03 8.17 6.29
14.5 9.31 15.1 11.6
74.6 47.8 77.6 59.7
1.48 0.95 1.54 1.18
0.053 0.036 0.055 0.042
1.23 0.79 1.28 0.99
2.04 1.31 2.13 1.64
10.3 6.59 10.7 8.24
5.01 3.21 5.21 4.01
14.5 9.29 15.1 11.6
0.095 0.061 0.099 0.079
22.7 2.1 23.6 18.1
Fig. 1. Chromatogram obtained following the conditions described in USP 34:
(A) full chromatogram and (B) expansion of the critical zone.
Table 5
Experiments of the factorial design.
Stda Runa Block Factors (k)
ITb FTb T ITc T FTc °C/min Fd
8 1 1 60 150 3 1 5 10
1 2 1 40 100 1 1 5 2.5
14 3 1 60 100 3 3 5 2.5
20 4 1 60 150 1 1 10 2.5
26 5 1 60 100 1 3 10 10
21 6 1 40 100 3 1 10 10
31 7 1 40 150 3 3 1 2.5
11 8 1 40 150 1 3 5 10
29 9 2 40 100 3 3 10 10
16 10 2 60 150 3 3 5 10
23 11 2 40 150 3 1 10 2.5
9 12 2 40 100 1 3 5 2.5
18 13 2 60 100 1 1 10 10
6 14 2 60 100 3 1 5 2.5
3 15 2 40 150 1 1 5 10
28 16 2 60 150 1 3 10 2.5
24 17 3 60 150 3 1 10 10
15 18 3 40 150 3 3 5 2.5
10 19 3 60 100 1 3 5 10
5 20 3 40 100 3 1 5 10
4 21 3 60 150 1 1 5 2.5
27 22 3 40 150 1 3 10 10
30 23 3 40 150 1 3 10 10
17 24 3 40 100 1 1 10 2.5
7 25 4 40 150 3 1 5 2.5
22 26 4 60 100 3 1 10 2.5
13 27 4 40 100 3 3 5 10
32 28 4 60 150 3 3 10 10
25 29 4 40 100 1 3 10 2.5
12 30 4 60 150 1 3 5 2.5
2 31 4 60 100 1 1 5 10
19 32 4 40 150 1 1 10 10
a Std refers to the standard order in the design. Run refers to the experiment
order.
b IT and FT in °C.
c T IT (time at initial temperature) and T FT (time at ﬁnal temperature) in
minutes.
d F in mL/min.
Table 6
Experiments and responses of the central composite design.
Stda Runa Block Factors (k) Responses
ITb FTb Fc R1 R2 R3 R4 R5
9 1 1 35.0 155.0 1.50 2.41 1.28 2.37 2.84 1.87
3 2 1 30.0 160.0 1.00 2.46 0.76 2.38 2.52 1.42
2 3 1 40.0 159.0 1.00 2.33 0.32 1.84 2.31 1.41
5 4 1 30.0 150.0 2.00 2.16 1.83 2.08 2.94 2.02
8 5 1 40.0 160.0 2.00 2.11 1.26 2.12 2.66 1.96
6 6 1 40.0 150.0 2.00 2.10 1.25 2.1 2.64 1.95
10 7 1 35.0 155.0 1.50 2.36 1.27 2.36 2.81 1.87
7 8 1 30.0 160.0 2.00 2.22 1.85 2.11 3.00 1.99
1 9 1 30.0 150.0 1.00 2.45 0.75 2.39 2.53 1.43
4 10 1 40.0 160.0 1.00 2.36 0.28 1.80 2.34 1.41
21 11 2 35.0 155.0 2.21 1.85 1.53 1.82 2.55 1.95
11 12 2 27.9 155.0 1.50 2.16 1.63 2.39 3.04 1.89
16 13 2 35.0 147.9 1.50 2.29 1.25 2.31 2.75 1.87
14 14 2 42.1 155.0 1.50 2.15 0.84 2.17 2.48 1.81
19 15 2 35.0 155.0 0.97 2.06 0.00 1.90 1.93 0.00
23 16 2 35.0 155.0 1.50 2.30 1.25 2.31 2.77 1.86
15 17 2 35.0 147.9 1.50 2.26 1.23 2.29 2.73 1.88
18 18 2 35.0 162.1 1.50 2.29 1.24 2.30 2.74 1.87
24 19 2 35.0 155.0 1.50 2.35 1.28 2.37 2.80 1.86
22 20 2 35.0 155.0 2.21 2.00 1.55 1.95 2.72 1.98
20 21 2 35.0 155.0 0.79 2.06 0.00 1.96 1.95 0.00
12 22 2 27.9 155.0 1.50 2.48 1.65 2.39 3.05 1.88
13 23 2 42.1 155.0 1.50 2.10 0.83 2.10 2.42 1.82
17 24 2 35.0 162.1 1.50 2.30 1.24 2.30 2.76 1.87
a Std refers to the standard order in the design. Run refers to the experiment
order.
b IT and FT in °C.
c F in mL/min.
Table 7
Models ﬁtting.
Response (y) Model Transformation Signiﬁcant
terms (xi)
ANOVA p-valuea
Model Lack of ﬁt
R1 Quadratic None A–C–C2 o0.0001 0.855
R2 Quadratic Power. Lamb-
da: 0.77
A–B–C–
AB–BC –
A2–B2–C2
o0.0001 0.572
R3 Quadratic None A–C–AC–
A2–C2
o0.0001 0.567
R4 Quadratic None A–C–C2 o0.0001 0.158
R5 Quadratic None A–C–AC–
A2–C2
o0.0001 0.238
A¼ Initial temperature (IT), B¼Final temperature (FT), C¼Flow (F).
a p-Values less than 0.050 indicate signiﬁcance.
Table 8
Criteria followed for the optimization of individual factors and responses.
Variable Goal Range Weight Importance
Lower limit Upper limit Lower Upper
IT Is in range 30 42 1 1 3
FT Is in range 148 162 1 1 3
F Is in range 0.80 2.48 1 1 3
R1 Maximize 1.85 2.48 0.5 1 3
(R2)0.77 Maximize 0.38 1.61 5 1 5
R3 Maximize 1.80 2.39 0.5 1 3
R4 Minimize 1.93 3.05 0.5 1 3
R5 Maximize 1.93 2.02 1 1 5
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of the ramp in the range of 5–10 °C/min; and (f) carrier gas ﬂow in
the range of 2.5–10 mL/min.
Several responses were selected for optimization purposes:
(R1) resolution between peaks of ethanol and ethyl ether, (R2)
resolution between peaks of acetone and 2-propanol, (R3) re-
solution between peaks of 2–propanol and acetonitrile, (R4) re-
solution between peaks of acetonitrile and methylene chloride,
and (R5) resolution between peaks of pyridine and toluene. These
resolutions were selected based on the fact that in none of the
runs these analytes had resolutions higher than 1.5.
Table 5 shows the fractional factorial design (6–1) built with 32
runs and blocked in 4 days. The analysis of the effects of the
variables over the responses was concluded that the factors with
no signiﬁcant inﬂuence on the chromatography resolution of
analyte were ramp rate (RR), time at ﬁnal temperature (T FT) and
time at initial temperature (T IT). While factors inﬂuencing the
resolution of the peaks were initial temperature (IT), ﬁnal tem-
perature (FT) and ﬂow (F).
With this information, we proceeded to build a central com-
posite design to ﬁnd out the optimal values of the factors under
study. Levels for each factor corresponding to –1 and þ1 coded
value were: 30.0 and 40.0 °C for IT, 150 and 160 °C for FT and
1.0 and 2.0 mL/min for F. The other chromatographic factors were
kept constant at the following values: 1.50 min for T IT, 1.50 min
for T FT and 5 °C/min for RR. The α-value used in the design was
compatible with rotatable distribution of prediction variance.Experiments were divided into two blocks, with 10 runs on day
one and 14 runs on day two, which are shown in Table 6 in their
actual values.
The experiments were performed in a randomized order to
Fig. 2. Individual desirability obtained for each variable.
Fig. 3. Desirability depending on ﬂow (F) and ﬁnal temperature (FT).
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uncontrolled factors. Then, the responses were evaluated and the
models were built.
2.9. Method validation
In order to study the linearity, calibration standards were
prepared in triplicate in DMSO. The central point of the calibra-
tions was chosen as the upper limit allowed by USP for each sol-
vent in raw material. In all cases, we used two sets of IS to
maintain constant their concentrations during the construction of
the curve. The headspace vapor of these solutions was introduced
into the instrument in a randomized way and calibration plots
were built by plotting concentration vs. relative areas (RA).
Limit of detection (LOD) and limit of quantiﬁcation (LOQ) were
calculated by the linear regression analysis and by using the sig-
nal/noise ratio criterion as described in the results.
To evaluate the trueness of the method, recovery experiments
were made with the fortiﬁed sample solutions described in Sec-
tion 2.7.
The instrumental repeatability was assessed by repetitive
measurements (n¼6) of standard solutions at the central point of
the calibration, whereas the intermediate precision was evaluated
by performing measurements (n¼5) of fortiﬁed samples at two
different concentrations (lower and upper levels of the curve)prepared by spiking metronidazole benzoate with a volume of an
adequately standard solution through two days. Then, the relative
standard deviation was calculated in all the cases.
The method was ﬁnally applied to the determination of RS in
raw material.3. Results and discussion
3.1. Optimization of the chromatographic separation
3.1.1. Models
In each model, the terms were evaluated by analysis of variance
(ANOVA) and a backward regression procedure was applied to
eliminate the insigniﬁcant factors (α¼0.10). This probability value,
α is used to limit the selection so that the terms with p-values
larger than 0.10 were excluded from the model. In this way, sim-
pliﬁed models, including only signiﬁcant terms and those neces-
sary to maintain hierarchy, were obtained. ANOVA is a collection of
statistical models used to analyze the differences between group
means. It estimated three sample variances: a total variance based
on all the observation deviations from the grand mean, an error
variance based on all the observation deviations from their ap-
propriate treatment means and a treatment variance. Treatment
considered in this case is the level of the factor. To determine the
Fig. 4. Chromatogram corresponding to a standard solution: (A) full chromato-
gram; (B) expansion of the critical zone and (C) DMSO blank.
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the variance between treatments with the variance within treat-
ment. Resulting models are shown in Table 7.
3.1.2. Transformation of the responses
Generally, transformation of the responses is used for three
different purposes: to stabilize the response variance, to do the
distribution of the response variable closer to the normal dis-
tribution, and to improve the ﬁt of the model to the experimental
data. The last objective includes model simpliﬁcation by elim-
inating interaction terms. Sometimes a transformation will be
reasonably effective in simultaneously accomplishing more than
one of these objectives.
Transformations apply a mathematical function to all the re-
sponse data needed in order to meet the assumptions that makethe ANOVA valid: residuals must be normally distributed, in-
dependent and with a constant variance.
There was a broad range of possible response transformations,
and the Box Cox graphical strategy was used in this work [22].
Table 7 shows the transformation of the responses made after
analyzing experimental results.
3.1.3. Optimal conditions achieved through desirability function
Table 8 shows the criteria chosen for the optimization of each
response. Due to the fact that they were the most critical para-
meters, an importance of 5 was assigned to R2 and R5 when
constructing the global desirability. The importance of the other
variables was kept in an intermediate value.
The global desirability function produced a maximum value
(D¼0.912) for IT of 30 °C, FT of 158 °C, and F of 1.90 mL/min in the
separative method.
Fig. 2 shows the partial desirability reached by each variable in
the system under the optimized conditions. Fig. 3 shows the global
desirability three-dimensionally represented as a function of two
of the inﬂuential variables in the system, depending on the ﬂow
rate and the ﬁnal temperature.
In setting the values that were assigned to the factors, the
following conﬁdence interval values (95% CI) for the ﬁve responses
were predicted by the ﬁtted models: R1¼2.19–2.31, R2¼1.40–
1.43, R3¼2.14–2.22, R4¼2.96–3.05 and R6¼2.00–2.02. The sug-
gested optimal conditions were then experimentally corroborated,
obtaining chromatographic signals like the one presented in Fig. 4.
3.2. Sample diluent selection
First, we used mixtures of water–DMSO and water–DMF ac-
cording to USP guide and then we used pure solvent (DMF and
DMSO). In the case of solvent–water mixtures, the equilibrium
temperature was maintained at 80 °C. In these experiments, a
remarkable decrease in the sensitivity of the analytes was ob-
served. For this reason, the incubation time was increased above
60 min in order to achieve satisfactory recoveries for the analytes
at concentrations of 1 μg/mL or less.
In addition, we considered the stability and solubility of the
raw materials to be analyzed. In this sense, DMF showed low
stability at high temperature and susceptibility to degradation
when exposed to ultrasonic during sample preparation. As the
degradation products may interfere with the determination, we
discarded the use of this solvent. Since DMSO is more stable at
high temperature and has a higher capacity of dissolving drug
substances and drugs products, it was chosen as the HS diluent.
3.3. Method validation and ﬁgures of merit
3.3.1. Speciﬁcity
In order to identify each analyte and their retention times in
our GC system with FID, we ran the pure solvents individually. As
it was previously described (Section 2.3) that several solvents have
the same retention time, we took the initiative to separate them
into two groups. The problem arose when a raw material had as
residual solvents a couple that overlap. In these cases, we either
changed the column using the same method or we developed a
new method for separating the analytes in question.
3.3.2. Linearity and range
According to Taverniers et al. [22], linearity is deﬁned as the
ability of the method to obtain test results proportional to the
concentration of analyte (within a given range) and linear range,
and, working range or linearity limits is deﬁned as the range of
concentrations (or amounts) of analyte over which the method
gives test results proportional to the concentration of analyte, or a
Table 9
Linearity range results and ﬁgures of merit (in all case the Ftab¼5.112).
Analyte Linearity range (mg/mL) Intercept Slope Fexpb r2 Lack of ﬁt (p-value)c
Propyl acetate 2.99–89.72 0.59 (0.23) 0.154 (0.004) 1.121 99.999 0.255
Acetone 3.00–90.06 0.077 (0.018) 0.122 (0.0003) 1.206 99.999 0.189
1-Butanol 3.02–90.51 0.59 (0.18) 0.115 (0.003) 1.089 99.395 0.306
Cyclohexane 2.99–89.75 0.22 (0.17) 0.337 (0.003) 1.097 99.934 0.296
Ethanol 2.99–89.94 –0.098 (0.027) 0.060 (0.0004) 0.837 99.945 0.837
Ethyl ether 2.99–89.84 0.144 (0.098) 0.111 (0.002) 1.276 99.797 0.143
Methanol 15.05–90.29 0.044 (0.017) 0.024 (0.0002) 1.330 99.914 0.126
Ethyl acetate 14.97–89.34 0.165 (0.029) 0.153 (0.0005) 1.154 99.994 0.237
Heptane 3.01–90.29 0.669 (0.212) 0.465 (0.004) 1.253 99.946 0.157
Hexane 1.44–8.64 0.024 (0.036) 0.917 (0.006) 1.987 99.125 0.361
2-Propanol 15.02–90.09 0.179 (0.058) 0.066 (0.0009) 0.932 99.868 0.570
Isopropyl ether 15.01–90.09 0.405 (0.284) 0.193 (0.005) 1.373 99.621 0.109
Tetrahydrofuran 0.46–13.89 0.023 (0.009) 0.196 (0.001) 0.932 99.972 0.589
Toluene 2.95–17.69 0.254 (0.039) 0.363 (0.0003) 1.319 99.948 0.130
Xylene 3.01–90.30 0.026 (0.019) 0.054 (0.003) 1.195 99.969 0.198
Acetonitrile 5.03–8.17 0.078 (0.005) 0.032 (0.0006) 1.090 99.640 0.305
Methylene chloride 9.31–15.12 0.048 (0.004) 0.020 (0.0003) 0.907 99.798 0.652
2-Butanone 47.75–77.60 0.041 (0.0005) 0.004 (0.0007) 1.178 99.728 0.212
Chloroform 0.95–1.54 0.332 (0.006) 0.428 (0.005) 0.978 99.905 0.496
Benzene 0.034–0.055 0.107 (0.006) 7.56 (0.12) 1.134 99.788 0.255
Triethylamine 0.79–1.28 1.46 (0.02) 1.86 (0.02) 1.308 99.929 0.126
Trichloroethylene 1.31–2.13 1.98 (0.03) 1.74 (0.02) 1.346 99.927 0.109
1,4-Dioxane 6.59–10.71 0.130 (0.007) 0.038 (0.0008) 1.239 99.627 0.166
Pyridine 3.21–5.21 0.269 (0.009) 0.123 (0.002) 1.064 99.748 0.341
Ethylene glycol 9.29–15.09 0.155 (0.008) 0.028 (0.0006) 1.174 99.580 0.215
Carbon tetrachloride 0.061–0.099 0.113 (0.004) 3.47 (0.005) 0.862 99.822 0.773
DMF 14.50–23.56 1.51 (0.05) 0.119 (0.002) 1.242 99.693 0.273
aValues between parentheses indicate SD.
b F-test for linearity determination.
c Since the p-value for the lack of adjustment is greater than or equal to 0.10, the model seems to be adequate for the observed data.
Table 10
LOD and LOQ values computed according to different criteria.
Analyte LODa LOQa
Calibration curve S/R Calibration curve S/R
Propyl acetate 9.1 8.2 28 27
Acetone 0.89 0.19 2.7 0.63
1-Butanol 9.2 8.7 28 29
Cyclohexane 3.0 2.0 9.1 6.7
Ethanol 2.7 1.3 8.2 4.3
Ethyl ether 5.3 5.0 16 17
Methanol 3.6 2.2 11 7.3
Ethyl acetate 0.96 0.91 2.9 3.0
Heptane 2.7 2.0 8.2 6.7
Hexane 0.20 0.16 0.61 0.53
2-Propanol 4.4 3.9 13 13
Isopropyl ether 7.5 7.1 23 24
Tetrahydrofuran 0.30 0.13 0.91 0.43
Toluene 0.54 0.36 1.6 1.2
Xylene 2.1 1.1 6.4 3.7
Acetonitrile 0.53 0.24 1.6 0.80
Methylene chloride 0.74 0.50 2.2 1.7
2-Butanone 4.4 3.6 13 12
Chloroform 0.05 0.06 0.15 0.20
Benzene 0.003 0.002 0.009 0.007
Triethylamine 0.04 0.08 0.12 0.27
Trichloroethylene 0.06 0.08 0.18 0.27
1,4-Dioxane 0.71 0.27 2.2 0.90
Pyridine 0.28 0.46 0.85 1.5
Ethylene glycol 1.1 0.81 3.3 2.7
Carbon tetrachloride 0.005 0.006 0.015 0.020
N,N-dimethylformamide 1.5 1.1 4.5 3.7
a Concentration in mg/mL.
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level.
Calibration curves were obtained with six standards covering
the selected range and each point in triplicate. Relative areas(analyte area/internal standard area) of each RS were calculated to
get the curve, plotting concentration vs. relative area (RA). All of RS
showed a good linear relationship (r240.99). The range and the
calibration parameters are listed in Table 9. However, for assess-
ment of the linearity of an analytical method, linear regression
calculations are not enough. Therefore, the goodness of ﬁt was
tested by comparing the variance of the lack of ﬁt against the pure
error variance [23,24]. The adequacy of the model was estimated
by an F-test which uses the pure error variance (SSPE/νPE) and the
variance of the lack of ﬁt (SSLOF/νLOF):
F SS / / SS / 2LOF LOF PE PEν ν= ( ) ( ) ( )
where SSPE is the sum of squares corresponding to pure error, SSLOF
is the sum of squares corresponding to the lack of ﬁt, νLOF¼νR–νPE,
and νPE and νR are the degrees of freedom for estimating the sum
of squares of pure error and residuals, respectively [25].
The calibration model is considered suitable if Fexp is
less than the one–tailed tabulated value Ftab(νR–νPE, νPE, p) at a p
conﬁdence level. In our case, the calibration model can be con-
sidered adequate as the Fexp, in all cases, lower than Ftab (Table 9).
3.3.3. LOD and LOQ
The LOD is the lowest concentration of analyte that can be
detected and reliably distinguished from zero (or the noise level of
the system), but not necessarily quantitated [22]. This parameter
was calculated using standard solutions prepared in solvent, ap-
plying different criteria.
First, the LOD was computed from the linear regression analysis
using the standard deviation of the regression (sy) using the ex-
pression LOD¼3.3sy/b [26].
Additionally, the LOD was calculated as the concentration of
analyte giving a signal three times of the noise level (S/N¼3),
using standard solutions prepared in solvent. The signal to noise
ratio was calculated using the Chemstation software version B.
The LOD values obtained by these criteria are displayed in
Table 11
Results of recoveries (%) for solvents of the ﬁrst calibration set.
Analyte Metronidazole benzoate Betamethasone-17 valerate
1a 2a 3a 4a 1a 2a 3a 4a
Propyl acetate 102.5 88.8 102.8 89.1 98.7 98.6 109.6 112.4
Acetone 97.6 102.7 90.1 89.5 87.6 94.5 88.3 90.3
1-Butanol 96.7 104.6 107.3 109.5 89.5 101.0 97.7 98.2
Cyclohexane 95.0 111.8 112.9 111.7 102.4 90.2 94.6 95.3
Ethanol 104.3 102.1 97.8 110.5 100.2 93.3 111.9 109.9
Ethyl ether 100.4 96.9 97.1 100.7 97.9 91.7 107.9 89.2
Methanol 98.1 94.2 100.4 104.4 99.3 100.8 92.3 108.7
Ethyl acetate 101.3 89.6 85.7 86.4 97.2 86.4 95.1 90.1
Heptane 106.9 95.8 86.5 86.6 102.6 91.4 103.4 102.6
Hexane 94.6 102.4 103.9 103.9 107.8 112.9 91.1 89.4
2-Propanol 99.1 105.9 93.7 91.2 102.3 88.3 103.9 97.1
Isopropyl ether 96.5 94.3 106.7 104.3 95.1 93.9 91.8 94.2
Tetrahydrofuran 111.3 91.6 90.0 102.2 91.1 99.7 91.7 90.3
Toluene 94.9 96.7 110.9 98.9 97.0 111.9 112.1 104.1
Xylene 110.1 101.7 108.5 98.7 106.3 109.1 111.8 108.5
a Fortiﬁcation level.
Table 12
Results of recoveries (%) for solvents of the second calibration set.
Analyte Metronidazole benzoate Betamethasone-17 valerate
1a 2a 3a 4a 1a 2a 3a 4a
Acetonitrile 96.2 104.8 113.1 110.8 95.6 98.3 98.9 97.7
Methylene chloride 88.6 90.4 105.1 108.6 109.6 98.3 104.9 107.0
2-Butanone 92.0 93.8 93.6 93.1 91.5 100.1 96.9 105.1
Chloroform 86.2 89.2 87.2 90.4 88.5 90.5 90.8 88.0
Benzene 91.3 88.0 99.0 88.2 89.8 96.3 101.7 109.0
Triethylamine 106.5 102.5 108.6 111.3 102.2 105.1 110.4 103.8
Trichloroethylene 100.2 91.8 99.8 99.4 93.3 100.3 105.5 98.9
1,4-Dioxane 104.3 109.1 112.1 107.3 99.8 104.8 108.1 103.7
Pyridine 110.9 109.5 110.4 104.9 103.0 105.0 104.5 98.9
Ethylene glycol 106.0 112.3 110.1 96.8 95.3 94.6 93.9 103.1
Carbon tetrachloride 108.3 106.0 105.7 96.3 100.0 99.7 101.0 94.7
DMF 92.1 95.6 98.1 105.6 103.2 101.3 109.2 107.5
a Fortiﬁcation level.
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According to different international regulatory bodies, the LOQ
is the lowest concentration of analyte that can be determined
quantitatively with an acceptable level of precision [22]. First, the
LOQ was computed from the linear regression analysis using the
standard deviation of the regression (sy) as was done for the LOD
but using a factor equal to 10. Additionally, it was calculated as the
concentration of analyte giving a signal ten times of the noise level
(S/N¼10) using standard solutions prepared in solvent.
The LOQ values obtained by these criteria are displayed in
Table 10.
3.3.4. Trueness
To assess the trueness of the method, recovery tests were made
by adding different concentrations of the solvents of interest to a
known mass of raw materials under study. The recoveries were
examined by spiking raw materials of metronidazole benzoate and
betamethasone-17 valerate with known amounts of standard so-
lutions at the beginning of the sample preparation procedure (see
Section 2.6). After analysis, the concentrations of the solvents were
obtained from the regression parameters of the calibration curves
and the recoveries were calculated. Four levels were evaluated
(three replicates), and the results are displayed in Table 11 and
Table 12. It can be observed that excellent recoveries were
achieved (between 85.7% and 113.1%).3.3.5. Precision
Two parameters were studied: repeatability or intra-assay
variations and intermediate precision or inter-assay variations
using fortiﬁed metronidazole benzoate raw material.
The relative standard deviation (RSD) of the obtained results
was evaluated and an F-test (α¼0.05) for comparison between
series was performed showing acceptable precision parameters for
the method. These results are displayed in Table 13.
3.4. Applications
The developed method was applied to residual solvents de-
termination in several commercial samples of metronidazole
benzoate and betamethasone-17 valerate raw material. In all cases,
we analyzed not only the solvents stated by manufacturer to be
used during the manufacturing process, but also the solvents that
were calibrated. In the great majority, the analyzed samples met
speciﬁcations containing solvents below allowable limits. How-
ever, there were cases in which the analyzed substances did not
meet speciﬁcations. An example of each case is shown in Table 14
and Table 15.
As it can be seen, through the developed method, it was pos-
sible to determine the solvents required by the manufacturer and
to identify and quantify other solvents that were not requested by
the manufacturer, and exceeded the permitted limits, such as
benzene in betamethasone-17 valerate and chloroform, dioxane
Table 13
Results of precision study.
Analyte Level 1 (%RSD) F between seriesa Level 2 (%RSD) F between Seriesa Inter assay (%RSD)
Day 1 Day 2 Day 1 Day 2
Propyl acetate 2.1 3.5 1.7 3.2 2.8 5.6 2.5
Acetone 4.0 3.2 1.1 2.7 3.6 8.2 2.4
1-Butanol 4.0 2.6 8.8 2.4 2.8 4.2 2.1
Cyclohexane 3.2 3.3 5.5 1.2 1.8 7.5 2.2
Ethanol 4.7 2.7 1.9 2.3 3.8 7.6 3.4
Ethyl ether 4.8 3.8 8.2 2.4 5.0 5.4 2.6
Methanol 6.2 3.6 2.1 2.1 3.4 7.5 3.7
Ethyl acetate 4.3 4.5 2.4 2.8 3.8 2.7 1.9
Heptane 4.7 4.7 2.1 2.2 2.9 5.3 2.4
Hexane 5.6 3.6 2.3 2.2 2.5 6.7 2.3
2-Propanol 5.8 3.0 2.3 2.0 3.8 4.8 2.8
Isopropyl ether 5.8 4.2 2.3 1.6 2.3 3.6 2.5
Tetrahydrofuran 3.2 2.9 2.2 3.6 3.2 3.8 2.5
Toluene 2.7 2.9 3.1 3.7 2.5 5.8 2.2
Xylene 4.2 3.3 1.7 2.2 3.0 9.0 2.1
Acetonitrile 3.9 3.4 1.1 3.0 3.0 1.3 2.8
Methylene chloride 3.5 3.1 2.5 2.9 2.4 3.4 2.5
2-Butanone 3.5 2.3 3.4 4.1 3.5 1.1 3.1
Chloroform 4.7 3.9 1.8 3.7 3.6 1.4 4.3
Benzene 4.3 3.0 1.6 2.3 3.0 1.0 3.3
Triethylamine 3.8 2.3 7.4 3.9 3.7 3.1 3.5
Trichloroethylene 2.9 2.7 4.8 2.4 3.3 1.9 2.3
1,4-Dioxane 3.8 2.3 1.2 2.4 3.6 1.0 2.0
Pyridine 2.9 3.0 1.2 3.9 3.4 3.1 2.6
Ethylene glycol 4.8 3.0 2.4 2.5 2.6 1.1 2.4
Carbon tetrachloride 3.6 3.2 1.9 5.5 3.2 4.3 3.5
DMF 3.0 3.4 5.0 4.8 2.6 4.8 2.8
a F-values. Fcrit(4,4); α¼0.05¼9.605.
Table 14
Concentration of analytes found in betamethasone-17 valerate raw material.
Analyte Class Concentration
(mg/g)
Individual
limit (mg/g)
Requested by the
manufacturer
Chloroform 2 oLOD 60 Yes
Trichlorethylene 2 oLOD 80 Yes
Dioxane 2 390 380 Yes
DMF 2 oLOD 880 Yes
Ethyl acetate 3 oLOD 5000 Yes
Methanol 2 1850 3000 No
2-Propanol 3 2440 5000 No
Methylene chloride 2 57 600 No
Benzene 1 12 2 No
Table 15
Concentration of analytes found in metronidazole benzoate raw material.
Analyte Class Concentration
(mg/g)
Individual
limit (mg/g)
Requested by the
manufacturer
Toluene 2 oLOD 890 Yes
Acetone 3 oLOD 5000 Yes
Ethylene
glycol
2 oLOD 620 Yes
Methanol 2 2270 3000 Yes
2-Propanol 3 oLOD 5000 Yes
Methylene
chloride
2 oLOD 600 Yes
Pyridine 2 307 200 No
Chloroform 2 364 60 No
Dioxane 2 1450 380 No
Ethyl acetate 3 188 5000 No
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used in traditional betamethasone synthesis procedures, such as
methanol, chloroform, tetrahydrofuran, dioxane and pyridine.Later, valerate is made from betamethasone and methyl ortovale-
rate as starting materials, using benzene as solvent [27]. Regarding
metronidazole, dioxane is commonly used as a dehydrogenating
agent in order to produce the precursors nitroimidazole drugs, in
an efﬁcient and economical manner [28]. Chloroform and ethyl
acetate are used as extractant and recristalization solvents in the
synthesis of metronidazole starting from nitroimidazole [27]. Fi-
nally, in the combination of benzoyl chloride and metronidazole to
obtain the benzoate form of metronidazole, pyridine is usually
employed as a deacid reagent to promote the reaction [29]. These
solvents are typically removed by evaporation under vacuum, but
it is clear that their removal from the raw material is sometimes
inadequate. In Fig. 5A and B the chromatograms obtained from the
analysis of these raw materials are shown.4. Conclusions
A systematic analytical approach for identiﬁcation and quan-
tiﬁcation of VOCs: methanol, ethanol, ethyl ether, acetone, 2-pro-
panol, acetonitrile, methylene chloride, hexane, isopropyl ether,
ethyl acetate, 2-butanone, chloroform, tetrahydrofuran, cyclohex-
ane, benzene, heptane, isooctane, triethylamine, 1-butanol, tri-
chloroethylene, 1,4-dioxane, propyl acetate, pyridine, toluene,
ethylene glycol, carbon tetrachloride, DMF, m-xylene, p-xylene,
o-xylene and DMSO in raw material is described in this article. A
simple general method utilizing static headspace capillary gas
chromatography coupled with FID was developed and provided an
effective means for rapid screening of VOCs. The use of chemo-
metric tools such as the experimental design and the multiple
response optimizations showed to be of great help to achieve a fast
and efﬁcient optimization of the chromatographic conditions.
A systematic study of VOCs in raw materials from various sources
is beyond the scope of this work. However, it is expected that the
presence and amount of VOCs in commercial materials will vary from
Fig. 5. Chromatograms corresponding to samples: (A) betamethasone-17 valerate
raw material (IS: acetone and hexane) and (B) metronidazole benzoate raw ma-
terial (IS: benzene and trichloroethylene).
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presented methodology should be guaranteed.Acknowledgments
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